Takeda Pharmaceutical (TAK) Institutional Ownership

$16.58 -0.04 (-0.21%)

Closing price 03:59 PM Eastern

Extended Trading

$16.57 0.00 (-0.03%)

As of 07:29 PM Eastern

Compare

Current Institutional Ownership Percentage: 9.17%
Number of Institutional Buyers (last 12 months): 212
Total Institutional Inflows (last 12 months): $298.87M

Number of Institutional Sellers (last 12 months): 113
Total Institutional Outflows (last 12 months): $259.96M

Get TAK Insider Trade Alerts

Want to know when executives and insiders are buying or selling Takeda Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TAK Institutional Buying and Selling by Quarter

Takeda Pharmaceutical Major Shareholders & Ownership History

Export

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/18/2026	Royal Bank of Canada	614,851	$11.39M	0.0%	+11.0%	0.019%
5/16/2026	Quantinno Capital Management LP	1,289,326	$23.88M	0.0%	+20.6%	0.041%
5/14/2026	Renaissance Technologies LLC	2,989,100	$55.36M	0.1%	+14.2%	0.094%
5/14/2026	Compound Planning Inc.	59,618	$1.10M	0.0%	+30.5%	0.002%
5/14/2026	Keebeck Wealth Management	12,647	$234K	0.0%	N/A	0.000%
5/14/2026	Arrowstreet Capital Limited Partnership	3,116,311	$57.71M	0.0%	-45.2%	0.098%
5/14/2026	Sei Investments Co.	229,943	$4.26M	0.0%	+20.3%	0.007%
5/14/2026	Lido Advisors LLC	22,886	$424K	0.0%	-17.4%	0.001%
5/13/2026	Cetera Investment Advisers	224,015	$4.15M	0.0%	+7.2%	0.007%
5/13/2026	First Trust Advisors LP	1,971,074	$36.50M	0.0%	-17.3%	0.062%
Get the Latest News and Ratings for TAK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Takeda Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.
5/8/2026	PNC Financial Services Group Inc.	56,714	$1.05M	0.0%	-3.7%	0.002%
5/8/2026	Summit Global Investments	116,494	$2.16M	0.1%	+11.6%	0.004%
5/7/2026	Dimensional Fund Advisors LP	135,679	$2.51M	0.0%	-16.9%	0.004%
5/7/2026	Parallel Advisors LLC	24,651	$457K	0.0%	+10.5%	0.001%
5/7/2026	Arjuna Capital	62,195	$1.15M	0.3%	+2.0%	0.002%
5/6/2026	Assetmark Inc.	227,616	$4.22M	0.0%	+45.8%	0.007%
5/6/2026	Gallacher Capital Management LLC	24,520	$454K	0.2%	+13.1%	0.001%
5/6/2026	Angeles Wealth Management LLC	13,535	$251K	0.0%	+16.5%	0.000%
5/6/2026	Allspring Global Investments Holdings LLC	28,944	$542K	0.0%	+41.9%	0.001%
5/5/2026	Bank of New York Mellon Corp	129,335	$2.40M	0.0%	+16.4%	0.004%
5/5/2026	Sanctuary Advisors LLC	29,457	$546K	0.0%	+24.7%	0.001%
5/5/2026	Checchi Capital Advisers LLC	14,591	$270K	0.0%	+5.7%	0.000%
5/4/2026	Empirical Financial Services LLC d.b.a. Empirical Wealth Management	45,942	$851K	0.0%	-2.0%	0.001%
5/4/2026	Bleakley Financial Group LLC	431,602	$7.99M	0.1%	+19.0%	0.014%
5/1/2026	Sequoia Financial Advisors LLC	98,936	$1.83M	0.0%	+18.9%	0.003%
5/1/2026	Manning & Napier Advisors LLC	218,977	$4.06M	0.1%	+1.5%	0.007%
4/29/2026	Jackson Thornton Wealth Management LLC	14,360	$260K	0.0%	+9.4%	0.000%
4/28/2026	Kathmere Capital Management LLC	15,932	$295K	0.0%	+44.3%	0.001%
4/28/2026	Abel Hall LLC	34,099	$632K	0.1%	+2.3%	0.001%
4/28/2026	DGS Capital Management LLC	23,106	$428K	0.1%	+63.1%	0.001%
4/28/2026	Walkner Condon Financial Advisors LLC	10,021	$186K	0.0%	N/A	0.000%
4/28/2026	QRG Capital Management Inc.	367,688	$6.81M	0.1%	+27.3%	0.012%
4/27/2026	HB Wealth Management LLC	17,055	$316K	0.0%	+41.9%	0.001%
4/27/2026	Private Advisor Group LLC	26,488	$491K	0.0%	+17.2%	0.001%
4/27/2026	Elevation Point Wealth Partners LLC	141,882	$2.63M	0.1%	+376.3%	0.004%
4/25/2026	Keybank National Association OH	39,215	$726K	0.0%	+205.3%	0.001%
4/25/2026	Pzena Investment Management LLC	28,360	$525K	0.0%	+37.5%	0.001%
4/24/2026	Fulton Bank N.A.	15,234	$282K	0.0%	N/A	0.000%
4/21/2026	SmartHarvest Portfolios LLC	13,905	$258K	0.1%	+34.8%	0.000%
4/21/2026	Aaron Wealth Advisors LLC	43,791	$811K	0.0%	+44.7%	0.001%
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
4/20/2026	Ritholtz Wealth Management	53,205	$985K	0.0%	+123.1%	0.002%
4/20/2026	Blue Trust Inc.	6,412	$119K	0.0%	-48.1%	0.000%
4/17/2026	Anchyra Partners LLC	12,466	$231K	0.1%	N/A	0.000%
4/16/2026	SG Americas Securities LLC	7,065	$131K	0.0%	-49.0%	0.000%
4/16/2026	Evolve Private Wealth LLC	26,029	$482K	0.0%	+4.5%	0.001%
3/17/2026	Rockefeller Capital Management L.P.	5,184	$81K	0.0%	+30.6%	0.000%
3/11/2026	Larry Mathis Financial Planning LLC	14,343	$224K	0.2%	N/A	0.000%
3/9/2026	Corient Private Wealth LLC	76,483	$1.19M	0.0%	-31.8%	0.002%
3/4/2026	Pure Financial Advisors LLC	10,528	$164K	0.0%	N/A	0.000%
3/4/2026	SHP Wealth Management	2,695	$42K	0.0%	N/A	0.000%
3/4/2026	Keenan LLC	17,513	$273K	0.2%	N/A	0.001%
2/24/2026	DGS Capital Management LLC	14,170	$221K	0.0%	-17.5%	0.000%
2/24/2026	SG Trading Solutions LLC	43,758	$682K	0.2%	N/A	0.001%
2/20/2026	Keenan LLC	10,941	$171K	9.8%	N/A	0.000%
2/19/2026	Compound Planning Inc.	45,673	$712K	0.0%	+8.3%	0.001%
2/19/2026	Corient Private Wealth LLC	91,363	$1.38M	0.0%	-18.5%	0.003%
2/18/2026	Mercer Global Advisors Inc. ADV	175,738	$2.74M	0.0%	-17.3%	0.006%
2/18/2026	Summit Global Investments	104,373	$1.63M	0.1%	+22.5%	0.003%
2/18/2026	Vident Advisory LLC	59,135	$922K	0.0%	-30.2%	0.002%
2/18/2026	EP Wealth Advisors LLC	23,081	$360K	0.0%	N/A	0.001%
2/18/2026	XTX Topco Ltd	71,476	$1.11M	0.0%	+437.7%	0.002%
2/18/2026	Voloridge Investment Management LLC	962,502	$15.01M	0.1%	+1,070.7%	0.030%
2/18/2026	Toronto Dominion Bank	823,200	$12.83M	0.0%	-72.6%	0.026%
2/18/2026	Evolve Private Wealth LLC	24,904	$388K	0.0%	N/A	0.001%
2/18/2026	Engineers Gate Manager LP	41,134	$641K	0.0%	+26.0%	0.001%
2/18/2026	Balyasny Asset Management L.P.	141,024	$2.20M	0.0%	N/A	0.004%
2/17/2026	Schonfeld Strategic Advisors LLC	115,250	$1.80M	0.0%	N/A	0.004%
2/17/2026	AQR Capital Management LLC	679,277	$10.59M	0.0%	-11.4%	0.021%
2/17/2026	Abel Hall LLC	33,318	$519K	0.1%	N/A	0.001%
2/17/2026	Cetera Investment Advisers	208,922	$3.26M	0.0%	-2.0%	0.007%
2/17/2026	Equitable Holdings Inc.	10,840	$169K	0.0%	-44.4%	0.000%
2/17/2026	Rexford Capital Inc.	8,585	$134K	0.1%	-7.0%	0.000%
2/17/2026	Laird Norton Wetherby Trust Company LLC	50,212	$783K	0.0%	N/A	0.002%
2/17/2026	Kotler Kevin	20,000	$312K	0.1%	N/A	0.001%
2/17/2026	Osaic Holdings Inc.	13,967	$218K	0.0%	-33.0%	0.000%
2/17/2026	Regal Investment Advisors LLC	28,698	$447K	0.0%	N/A	0.001%
2/17/2026	Russell Investments Group Ltd.	99,982	$1.56M	0.0%	+5.0%	0.003%
2/17/2026	Captrust Financial Advisors	118,774	$1.85M	0.0%	+189.0%	0.004%
2/17/2026	&PARTNERS	28,629	$446K	0.0%	+9.8%	0.001%
2/17/2026	Blair William & Co. IL	10,011	$156K	0.0%	N/A	0.000%
2/17/2026	Royal Bank of Canada	554,126	$8.64M	0.0%	+13.2%	0.017%
2/16/2026	Vanguard Personalized Indexing Management LLC	135,397	$2.11M	0.0%	-22.7%	0.004%
2/16/2026	MML Investors Services LLC	101,844	$1.59M	0.0%	+13.6%	0.003%
2/16/2026	Mariner LLC	187,640	$2.93M	0.0%	-24.6%	0.006%
2/16/2026	Focus Partners Wealth	562,049	$8.76M	0.0%	+458.7%	0.018%
2/16/2026	Entropy Technologies LP	42,831	$668K	0.0%	+103.2%	0.001%
2/16/2026	Arax Advisory Partners	7,178	$112K	0.0%	-88.3%	0.000%
2/16/2026	Arrowstreet Capital Limited Partnership	5,682,847	$88.60M	0.1%	+100.9%	0.179%
2/13/2026	Kestra Advisory Services LLC	6,477	$101K	0.0%	N/A	0.000%
2/13/2026	Parkside Financial Bank & Trust	2,560	$40K	0.0%	+192.2%	0.000%
Your $29.97 book is free today (Ad) Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account. Normally $29.97. Today it's free. Grab your copy now.
2/13/2026	Corient IA LLC	14,880	$232K	0.2%	-40.5%	0.000%
2/13/2026	Walleye Capital LLC	83,083	$1.30M	0.0%	-62.5%	0.003%
2/13/2026	Stifel Financial Corp	554,290	$8.64M	0.0%	+8.9%	0.017%
2/13/2026	PCM Encore LLC	75,790	$1.18M	0.3%	N/A	0.002%
2/13/2026	Smartleaf Asset Management LLC	24,772	$387K	0.0%	+24.5%	0.001%
2/13/2026	Bridgefront Capital LLC	36,579	$570K	0.1%	-56.3%	0.001%
2/13/2026	Morgan Stanley	6,373,202	$99.36M	0.0%	-17.1%	0.200%
2/13/2026	Focused Alpha LLC	14,180	$221K	0.1%	N/A	0.000%
2/13/2026	First Trust Advisors LP	2,382,629	$37.15M	0.0%	-5.4%	0.075%
2/13/2026	Charles Schwab Investment Management Inc.	413,692	$6.45M	0.0%	+7.2%	0.013%

TAK Institutional Ownership - Frequently Asked Questions

During the previous two years, 316 institutional investors and hedge funds held shares of Takeda Pharmaceutical. The most heavily invested institutionals were Capital Research Global Investors ($210.26M), Mondrian Investment Partners LTD ($108.34M), Morgan Stanley ($99.36M), Goldman Sachs Group Inc. ($74.90M), UBS Group AG ($64.29M), Brandes Investment Partners LP ($60.52M), and Arrowstreet Capital Limited Partnership ($57.71M).Learn more on Takeda Pharmaceutical's institutional investors.

9.17% of Takeda Pharmaceutical's stock is owned by institutional investors. Learn more on TAK's institutional investor holdings.

Of the 291 institutional investors that purchased Takeda Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Arrowstreet Capital Limited Partnership ($4.46M), Adage Capital Partners GP L.L.C. ($3.43M), Millennium Management LLC ($2.02M), UBS Group AG ($1.87M), Van ECK Associates Corp ($1.67M), Qube Research & Technologies Ltd ($1.48M), and Voloridge Investment Management LLC ($1.09M).

Institutional investors have bought a total of 19,398,300 shares in the last 24 months. This purchase volume represents approximately $298.87M in transactions.

Of the 113 institutional investors that sold Takeda Pharmaceutical's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Arrowstreet Capital Limited Partnership ($2.75M), Toronto Dominion Bank ($2.18M), UBS Group AG ($1.77M), Jane Street Group LLC ($1.65M), Morgan Stanley ($1.32M), Renaissance Technologies LLC ($1.25M), and Adage Capital Partners GP L.L.C. ($899.30K).

Institutional investors have sold a total of 16,243,226 shares in the last 24 months. This volume of shares sold represents approximately $259.96M in transactions.

Related Companies

This page (NYSE:TAK) was last updated on 5/18/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Takeda Pharmaceutical (TAK) Institutional Ownership

TAK Institutional Buying and Selling by Quarter

Takeda Pharmaceutical Major Shareholders & Ownership History

TAK Institutional Ownership - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Takeda Pharmaceutical (TAK) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Takeda Pharmaceutical (NYSE:TAK)

TAK Institutional Buying and Selling by Quarter

Takeda Pharmaceutical Major Shareholders & Ownership History

TAK Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of TAK shares?

What percentage of Takeda Pharmaceutical's stock is owned by institutional investors?

Which institutional investors have been buying Takeda Pharmaceutical's stock?

How much institutional buying is happening at Takeda Pharmaceutical?

Which of Takeda Pharmaceutical's major shareholders have been selling company stock?

How much institutional selling is happening at Takeda Pharmaceutical?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools